spacer
spacer

PDBsum entry 6vms

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Signaling protein PDB id
6vms

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
227 a.a.
339 a.a.
59 a.a.
232 a.a.
278 a.a.
Ligands
08Y
PDB id:
6vms
Name: Signaling protein
Title: Structure of a d2 dopamine receptor-g-protein complex in a lipid membrane
Structure: Guanine nucleotide-binding protein g(i) subunit alpha-1. Chain: a. Synonym: adenylate cyclase-inhibiting g alpha protein. Engineered: yes. Guanine nucleotide-binding protein g(i)/g(s)/g(t) subunit beta-1. Chain: b. Synonym: transducin beta chain 1. Engineered: yes.
Source: Rattus norvegicus. Rat. Organism_taxid: 10116. Gene: gnai1, gnai-1. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Homo sapiens. Human. Organism_taxid: 9606.
Authors: J.Yin,K.M.Chen,M.J.Clark,M.Hijazi,P.Kumari,X.Bai,R.K.Sunahara, P.Barth,D.M.Rosenbaum
Key ref: J.Yin et al. (2020). Structure of a D2 dopamine receptor-G-protein complex in a lipid membrane. Nature, 584, 125-129. PubMed id: 32528175 DOI: 10.1038/s41586-020-2379-5
Date:
28-Jan-20     Release date:   17-Jun-20    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P10824  (GNAI1_RAT) -  Guanine nucleotide-binding protein G(i) subunit alpha-1 from Rattus norvegicus
Seq:
Struc:
354 a.a.
227 a.a.*
Protein chain
Pfam   ArchSchema ?
P62873  (GBB1_HUMAN) -  Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 from Homo sapiens
Seq:
Struc:
340 a.a.
339 a.a.
Protein chain
Pfam   ArchSchema ?
P59768  (GBG2_HUMAN) -  Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 from Homo sapiens
Seq:
Struc:
71 a.a.
59 a.a.
Protein chain
No UniProt id for this chain
Struc: 232 a.a.
Protein chain
Pfam   ArchSchema ?
D9IEF7  (D9IEF7_BPT4) -  Endolysin from Enterobacteria phage T4
Seq:
Struc:
164 a.a.
278 a.a.*
Protein chain
Pfam   ArchSchema ?
P14416  (DRD2_HUMAN) -  D(2) dopamine receptor from Homo sapiens
Seq:
Struc:
443 a.a.
278 a.a.*
Key:    PfamA domain  Secondary structure
* PDB and UniProt seqs differ at 157 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class 1: Chain A: E.C.3.6.5.-  - ?????
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 2: Chain R: E.C.3.2.1.17  - lysozyme.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Hydrolysis of the 1,4-beta-linkages between N-acetyl-D-glucosamine and N-acetylmuramic acid in peptidoglycan heteropolymers of the prokaryotes cell walls.
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.

 

 
DOI no: 10.1038/s41586-020-2379-5 Nature 584:125-129 (2020)
PubMed id: 32528175  
 
 
Structure of a D2 dopamine receptor-G-protein complex in a lipid membrane.
J.Yin, K.M.Chen, M.J.Clark, M.Hijazi, P.Kumari, X.C.Bai, R.K.Sunahara, P.Barth, D.M.Rosenbaum.
 
  ABSTRACT  
 
The D2 dopamine receptor (DRD2) is a therapeutic target for Parkinson's disease1 and antipsychotic drugs2. DRD2 is activated by the endogenous neurotransmitter dopamine and synthetic agonist drugs such as bromocriptine3, leading to stimulation of Gi and inhibition of adenylyl cyclase. Here we used cryo-electron microscopy to elucidate the structure of an agonist-bound activated DRD2-Gi complex reconstituted into a phospholipid membrane. The extracellular ligand-binding site of DRD2 is remodelled in response to agonist binding, with conformational changes in extracellular loop 2, transmembrane domain 5 (TM5), TM6 and TM7, propagating to opening of the intracellular Gi-binding site. The DRD2-Gi structure represents, to our knowledge, the first experimental model of a G-protein-coupled receptor-G-protein complex embedded in a phospholipid bilayer, which serves as a benchmark to validate the interactions seen in previous detergent-bound structures. The structure also reveals interactions that are unique to the membrane-embedded complex, including helix 8 burial in the inner leaflet, ordered lysine and arginine side chains in the membrane interfacial regions, and lipid anchoring of the G protein in the membrane. Our model of the activated DRD2 will help to inform the design of subtype-selective DRD2 ligands for multiple human central nervous system disorders.
 

 

spacer

spacer